Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...

Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS ...

New research supports brain cell transplantation as a treatment for some neurological disorders. A team from McGill ...

Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...

Aaron Lazar received his first-ever Grammy nomination on Friday, Nov. 8 for his debut album, 'Impossible Dream.' It was an ...

Tal Newberry passed from Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease on Christmas Day in ...

This November, the nonprofit I AM ALS is launching a peer support program as part of its new campaign focused on supporting ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...

Neurizon has been buoyed by the receipt of a positive opinion from the European Medicines Agency in relation to its ... Read ...

He introduced ticket prices that couldn’t be beat, but asked fliers to pay extra for nearly everything, including water, ...

Report Ocean, a leading strategic consulting, and Market research firm, in its recent study, estimated Global Amayotrophic Lateral Sclerosis (ALS) Market size by value at USD 902 million in 2023.

The mutations were mapped by a group at the Federal University of São Paulo and collaborators in an analysis of mitochondrial genomes. Thirteen increase the risk of ALS and 38 are protective.